PUBLISHER: The Business Research Company | PRODUCT CODE: 1948390
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948390
Urinary tract infection (UTI) testing devices are medical instruments designed to diagnose infections in the urinary system by identifying bacteria, white blood cells, or other indicators in urine samples. These devices vary from simple dipsticks and culture kits to more sophisticated automated analyzers, offering fast and precise results that help guide treatment decisions.
The primary types of UTI testing devices include instruments and kits. UTI testing kits are popular for their convenience and affordability, making them commonly used in point-of-care environments and for self-testing. The different types of tests include urinalysis, urine cultures, and susceptibility testing, and they are utilized by various end-users such as hospitals, diagnostic laboratories, and other healthcare providers.
Tariffs are impacting the urinary tract infection testing devices market by increasing costs of diagnostic reagents, sensors, and automated analyzer components. Instrument and kit segments are most affected, particularly in North America and Europe due to dependence on Asia-Pacific manufacturing. While tariffs have raised testing costs, they have also driven local kit production, streamlined reagent usage, and innovation in cost-effective rapid testing solutions.
The urinary tract infection testing devices market research report is one of a series of new reports from The Business Research Company that provides urinary tract infection testing devices market statistics, including urinary tract infection testing devices industry global market size, regional shares, competitors with a urinary tract infection testing devices market share, detailed urinary tract infection testing devices market segments, market trends and opportunities, and any further data you may need to thrive in the urinary tract infection testing devices industry. This urinary tract infection testing devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The urinary tract infection testing devices market size has grown strongly in recent years. It will grow from $0.66 billion in 2025 to $0.71 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to high prevalence of UTIs, hospital diagnostic workload growth, routine urinalysis adoption, demand for faster diagnosis, expansion of diagnostic laboratories.
The urinary tract infection testing devices market size is expected to see strong growth in the next few years. It will grow to $0.9 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to point-of-care testing expansion, AI-assisted urine analysis, growth in home diagnostics, rising antimicrobial resistance concerns, rapid diagnostic kit innovation. Major trends in the forecast period include rapid point-of-care UTI testing, automated urinalysis systems, home-based UTI testing kits, improved bacterial detection accuracy, antibiotic susceptibility screening.
The increasing prevalence of urinary tract infections (UTIs) is expected to drive the growth of the urinary tract infection testing devices market. UTIs can affect any part of the urinary system, such as the kidneys, ureters, bladder, or urethra, and are commonly caused by bacteria, with Escherichia coli being the most frequent pathogen. The rise in UTI cases is attributed to factors such as prolonged catheter use, poor hygiene practices, and growing antimicrobial resistance among hospitalized patients. UTI testing devices assist in the rapid and accurate diagnosis of UTIs, enabling healthcare providers to identify the causative bacteria and administer targeted treatments quickly. This helps reduce complications, improve patient outcomes, and limit the spread of antimicrobial resistance within healthcare environments. According to the University of New South Wales, a public research university in Australia, UTIs are widespread, with over 400 million cases reported globally each year. As a result, the rising incidence of UTIs is fueling the demand for urinary tract infection testing devices.
Leading companies in the UTI testing devices market are focusing on developing point-of-care (POC) testing devices that offer quicker, more convenient diagnoses, improving patient care. POC testing allows medical diagnostics to be performed at or near the patient's location, such as at a doctor's office, hospital bedside, or even at home, without the need for laboratory sample processing. For example, in June 2023, Sysmex Corporation, a Japanese company, introduced the PA-100 AST System, a point-of-care testing system for detecting antimicrobial susceptibility. This system can identify bacterial presence in urine and assess the effectiveness of antimicrobials in under 30 minutes. It provides results on bacterial growth in about 10 minutes and offers susceptibility test outcomes in less than 30 minutes, enabling healthcare professionals to conduct rapid tests on patients suspected of having UTIs.
In August 2024, Alpha Laboratories Ltd., a UK-based diagnostics and laboratory supplies company, entered into a strategic partnership with Clinical Design Technologies Ltd. to market and support the UTS digital closed urine testing system, with the objective of transforming point-of-care urinalysis by enabling faster, more accurate results and improving clinical efficiency. Clinical Design Technologies Ltd. is a UK-based medical device company that developed the UTS (Urine Testing System), a digital closed urinalysis platform designed for rapid, point-of-care urine testing that streamlines clinical workflows and provides precise diagnostic data.
Major companies operating in the urinary tract infection testing devices market are Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, bioMerieux SA, Bio-Rad Laboratories, QIAGEN NV, Sysmex Corporation, Quidel Corporation, ACON Laboratories Inc., Randox Laboratories Ltd., ARKRAY Inc., T2 Biosystems Inc., Cepheid, Meridian Bioscience Inc., Luminex Corporation, Beckman Coulter Inc., OraSure Technologies Inc., Mesa Biotech Inc.
North America was the largest region in the urinary tract infection testing devices market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urinary tract infection testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the urinary tract infection testing devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The urinary tract infection (UTI) testing devices market consists of sales of urine analyzers, dipsticks, and culture systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Urinary Tract Infection Testing Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses urinary tract infection testing devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for urinary tract infection testing devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The urinary tract infection testing devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.